NICE Recommends PD-1 Inhibitor for Advanced Anal Cancer

1 source1 article First seen 1 day ago Updated 1 day ago United Kingdom Truth score 38

Save Like Comments Compare coverage

Summary

NICE said around 250 people in England could benefit from retifanlimab, now recommended with chemotherapy for advanced anal cancer. Medscape News UK

Description from Medscape.

Medscape Center Factuality: Mostly factual US 1 day ago
NICE Recommends PD-1 Inhibitor for Advanced Anal Cancer
NICE said around 250 people in England could benefit from retifanlimab, now recommended with chemotherapy for advanced anal cancer. Medscape News UK

Comments need JavaScript.

38/100Weakly supported

How well the story is corroborated by independent, reliable outlets across the spectrum. Not a fact-check of each claim. How the truth score works

Centre 100%100%